S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
$0.09
$0.13
$0.06
$0.30
$5.06M0.3427,757 shs2,000 shs
Positron Co. stock logo
POSC
Positron
$1.10
-0.9%
$1.29
$0.87
$1.97
$28.78M0.984,784 shs4,115 shs
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
$37.90
+0.3%
$44.39
$3.16
$53.82
$1.23B-1.56300,526 shs203,066 shs
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
$1.11
+0.9%
$1.25
$1.00
$23.79
$1.63M2.88109,676 shs13,873 shs
Vaso Co. stock logo
VASO
Vaso
$0.30
-3.3%
$0.30
$0.19
$0.37
$57.45M2.03127,697 shs27,567 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
-5.10%-20.78%-28.83%-43.13%-63.56%
Positron Co. stock logo
POSC
Positron
-7.50%-11.20%-16.84%-11.90%-33.13%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-1.90%-8.03%-13.05%-15.87%+964.51%
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
+0.47%-8.74%-13.09%-21.22%-92.52%
Vaso Co. stock logo
VASO
Vaso
+12.96%+10.65%+1.48%+3.51%+25.30%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Positron Co. stock logo
POSC
Positron
N/AN/AN/AN/AN/AN/AN/AN/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
4.1363 of 5 stars
3.51.00.04.62.34.20.6
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
N/AN/AN/AN/AN/AN/AN/AN/A
Vaso Co. stock logo
VASO
Vaso
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
N/AN/AN/AN/A
Positron Co. stock logo
POSC
Positron
N/AN/AN/AN/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3.00
Buy$55.6046.70% Upside
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
N/AN/AN/AN/A
Vaso Co. stock logo
VASO
Vaso
N/AN/AN/AN/A

Current Analyst Ratings

Latest SLNO, VASO, GTHP, POSC, and TIVC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
2/5/2024
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$93.00
1/23/2024
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$63.00
(Data available from 4/17/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
$100K50.61N/AN/A($0.13) per share-0.70
Positron Co. stock logo
POSC
Positron
$740K38.54N/AN/A($0.04) per share-27.50
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/AN/AN/AN/A$5.16 per shareN/A
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
$1.18M1.38N/AN/A$2.44 per share0.45
Vaso Co. stock logo
VASO
Vaso
$83.05M0.66$0.03 per share8.76$0.14 per share2.11

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
-$3.49MN/A0.00N/AN/AN/A-158.84%5/13/2024 (Estimated)
Positron Co. stock logo
POSC
Positron
-$1.64MN/A0.00N/A-222.99%N/A-65.25%N/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-$38.99M-$2.97N/AN/AN/AN/A-79.65%-52.92%5/14/2024 (Estimated)
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
-$8.24M-$42.48N/AN/A-701.02%-186.19%-138.20%5/20/2024 (Estimated)
Vaso Co. stock logo
VASO
Vaso
$4.80M$0.039.84N/A5.93%19.02%6.59%5/13/2024 (Estimated)

Latest SLNO, VASO, GTHP, POSC, and TIVC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/6/2024Q4 2023
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-$0.31-$0.33-$0.02-$0.33N/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
N/AN/AN/AN/AN/A
Positron Co. stock logo
POSC
Positron
N/AN/AN/AN/AN/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/AN/AN/AN/AN/A
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
N/AN/AN/AN/AN/A
Vaso Co. stock logo
VASO
Vaso
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
N/A
0.29
0.16
Positron Co. stock logo
POSC
Positron
N/A
0.70
0.06
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/A
14.89
14.89
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
N/A
3.32
2.78
Vaso Co. stock logo
VASO
Vaso
N/A
1.50
1.45

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
9.69%
Positron Co. stock logo
POSC
Positron
N/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
97.42%
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
4.25%
Vaso Co. stock logo
VASO
Vaso
N/A

Insider Ownership

CompanyInsider Ownership
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
66.83%
Positron Co. stock logo
POSC
Positron
17.20%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
28.80%
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
2.70%
Vaso Co. stock logo
VASO
Vaso
44.56%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
455.61 million18.45 millionNot Optionable
Positron Co. stock logo
POSC
Positron
1925.93 million21.47 millionNot Optionable
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3332.46 million23.11 millionOptionable
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
91.47 million1.43 millionNot Optionable
Vaso Co. stock logo
VASO
Vaso
272185.63 million102.91 millionNot Optionable

SLNO, VASO, GTHP, POSC, and TIVC Headlines

SourceHeadline
Unity Biotechnology gets grant for senolytic agents for treating age-related eye conditionsUnity Biotechnology gets grant for senolytic agents for treating age-related eye conditions
pharmaceutical-technology.com - April 17 at 1:30 PM
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of bluebird bioDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of bluebird bio
markets.businessinsider.com - April 16 at 11:07 PM
One bold initiative to recruit Mexican doctors to help bridge language barriers back homeOne bold initiative to recruit Mexican doctors to help bridge language barriers back home
whyy.org - April 15 at 12:04 PM
Interior ministry confirms European Parliament and local government elections for June 9Interior ministry confirms European Parliament and local government elections for June 9
msn.com - April 13 at 1:40 AM
Sun shines on Imbros’ Anzac connection in SydneySun shines on Imbros’ Anzac connection in Sydney
neoskosmos.com - April 12 at 8:40 PM
Short Interest in Vaso Co. (OTCMKTS:VASO) Decreases By 45.9%Short Interest in Vaso Co. (OTCMKTS:VASO) Decreases By 45.9%
americanbankingnews.com - April 11 at 5:30 AM
Vaso Co. (OTCMKTS:VASO) Sees Large Drop in Short InterestVaso Co. (OTCMKTS:VASO) Sees Large Drop in Short Interest
americanbankingnews.com - April 11 at 4:56 AM
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BlueSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
markets.businessinsider.com - April 10 at 8:15 PM
BLUE INVESTOR DEADLINE: bluebird bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitBLUE INVESTOR DEADLINE: bluebird bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
stockhouse.com - April 5 at 8:06 PM
Vaso KotroniVaso Kotroni
avclub.com - April 4 at 1:59 PM
Greek top court orders charges against far-right MPs for deceiving votersGreek top court orders charges against far-right MPs for deceiving voters
msn.com - April 4 at 1:59 PM
COMING IN HOT! KIMPTON MAA-LAI BANGKOKS ICONIC "CHILLI FEST" RETURNS FOR A SECOND YEARCOMING IN HOT! KIMPTON MAA-LAI BANGKOK'S ICONIC "CHILLI FEST" RETURNS FOR A SECOND YEAR
ryt9.com - April 4 at 8:59 AM
Shelf Life: Julia AlvarezShelf Life: Julia Alvarez
msn.com - April 2 at 4:48 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio, Inc. - BLUESHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio, Inc. - BLUE
stockhouse.com - April 2 at 4:48 PM
Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year of 2023Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year of 2023
globenewswire.com - April 1 at 4:05 PM
New therapies in treatment of sickle cell anemiaNew therapies in treatment of sickle cell anemia
msn.com - April 1 at 12:07 PM
6 Recently Approved Cell & Gene Therapies—And Why They Matter6 Recently Approved Cell & Gene Therapies—And Why They Matter
biospace.com - April 1 at 2:06 AM
Tim Tszyu suffers devastating first loss to Sebastian Fundora in Las VegasTim Tszyu suffers devastating first loss to Sebastian Fundora in Las Vegas
theaustralian.com.au - March 31 at 4:05 PM
Tim Tszyu v Sebastian Fundora in Las Vegas: result and latest newsTim Tszyu v Sebastian Fundora in Las Vegas: result and latest news
thechronicle.com.au - March 31 at 12:18 AM
A Performance Art Piece Is Coming to the National Mall for Trans Day of VisibilityA Performance Art Piece Is Coming to the National Mall for Trans Day of Visibility
washingtonian.com - March 30 at 2:17 PM
A Monument to the PastA Monument to the Past
thelancet.com - March 29 at 11:15 PM
Wenda Kay Patrick, Masury, OhioWenda Kay Patrick, Masury, Ohio
wkbn.com - March 29 at 6:14 PM
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BlueDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
markets.businessinsider.com - March 29 at 6:14 PM
Romanian writer Mircea Cărtărescu honored with International Premio MondelloRomanian writer Mircea Cărtărescu honored with International Premio Mondello
business-review.eu - March 28 at 10:08 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Guided Therapeutics logo

Guided Therapeutics

OTCMKTS:GTHP
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Positron logo

Positron

OTCMKTS:POSC
Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.
Soleno Therapeutics logo

Soleno Therapeutics

NASDAQ:SLNO
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.
Tivic Health Systems logo

Tivic Health Systems

NASDAQ:TIVC
Tivic Health Systems Inc. operates as a health technology company, focuses on developing and commercializing non-invasive bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal congestion pains. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
Vaso logo

Vaso

OTCMKTS:VASO
Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging capital equipment, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems that are used for non-invasive, outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.